ABL2	chr1	179,099,327	179,229,684	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ABL2 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
AFF1	chr4	86,935,002	87,141,054	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the AFF1 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ASXL1	chr20	32,358,343	32,439,319	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ASXL1 gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CDKN1B	chr12	12,717,368	12,722,371	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CDKN1B gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CDKN2A	chr9	21,967,752	21,994,492	-	NA	NA	Yes	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T/B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CDKN2A gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CEBPA	chr19	33,299,934	33,302,564	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CEBPA gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CREBBP	chr16	3,725,055	3,880,120	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CREBBP gene on chr16 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CRLF2	chrX	1,198,411	1,198,437	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CRLF2 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CRLF2	chrX	1,198,240	1,198,272	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CRLF2 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CRLF2	chrX	1,198,212	1,198,240	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CRLF2 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CRLF2	chrX	1,198,245	1,198,272	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CRLF2 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CRLF2	chrY	1,198,180	1,198,396	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CRLF2 gene on chrY with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CSF1R	chr5	150,053,290	150,113,372	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CSF1R gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
EBF1	chr5	158,695,915	159,099,780	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EBF1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
EPOR	chr19	11,377,204	11,384,342	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EPOR gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ERG	chr21	38,380,028	38,661,780	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ERG gene on chr21 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
EWSR1	chr22	29,268,009	29,300,525	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EWSR1 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
EZH2	chr7	148,807,372	148,884,349	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EZH2 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
FGFR1	chr8	38,411,137	38,468,834	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FGFR1 gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
FLT3	chr13	28,003,274	28,100,592	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FLT3 gene on chr13 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
FOXP1	chr3	70,954,713	71,583,989	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FOXP1 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
JAK1	chr1	64,833,223	64,966,504	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the JAK1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
JAK2	chr9	4,985,245	5,128,183	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the JAK2 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
JAK3	chr19	17,824,784	17,848,032	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the JAK3 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
KRAS	chr12	25,205,245	25,250,920	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the KRAS gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MLLT1	chr19	6,210,381	6,279,948	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MLLT1 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MLLT10	chr10	21,534,172	21,743,630	+	NA	NA	Yes	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T/B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MLLT10 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MLLT3	chr9	20,341,665	20,622,543	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MLLT3 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
MLLT4	chr6	167,826,991	167,972,020	NA	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MLLT4 gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NF1	chr17	31,094,927	31,377,677	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NF1 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NR3C1	chr5	143,277,930	143,435,512	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NR3C1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NRAS	chr1	114,704,463	114,716,894	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NRAS gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NTRK3	chr15	87,876,757	88,256,731	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NTRK3 gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
NUP214	chr9	131,125,561	131,234,670	+	NA	NA	Yes	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T/B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NUP214 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
P2RY8	chrX	1,462,573	1,537,144	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the P2RY8 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PDGFRB	chr5	150,113,839	150,155,859	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PDGFRB gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PML	chr15	73,994,672	74,047,814	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PML gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PTPN11	chr12	112,418,732	112,509,913	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PTPN11 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RB1	chr13	48,303,746	48,481,890	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the RB1 gene on chr13 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SH2B3	chr12	111,405,947	111,451,623	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SH2B3 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
SYK	chr9	90,801,729	90,898,560	+	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the SYK gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TP53	chr17	7,668,402	7,687,550	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TP53 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TYK2	chr19	10,350,528	10,380,572	-	NA	NA	Yes	No	Yes	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TYK2 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PAX5	chr9	36,833,269	37,034,268	-	NA	Classification of B-ALL; B-ALLwith mutated PAX5 P80R. Provisional entity: B-ALL, with PAX5 alteration (PMID: 36422706)	Yes	No	Yes	N.A.	Duplication/CN gain	GOF	ALL	3A or B depending on size	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the PAX5 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant is associated with a intermediate, good in adults prognosis (PMID: 36422706).
ABL1	chr9	130,713,043	130,887,675	+	B-lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1, B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features, B-lymphoblastic leukaemia/lymphoma, BCR-ABL1- like, B-lymphoblastic leukaemia/lymphoma with KMT2Arearrangement, (WHO, PMID: 35732831).	B-ALL with t(9;22)(q34.1;q11.2)/BCR::ABL1 (PMID: 36422706)	Yes	Yes	Yes	NA	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the ABL1 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ETV6	chr12	11,649,674	11,895,377	+	B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion, B-lymphoblastic leukaemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1, (WHO, PMID: 35732831).	Classification of B-ALL B-ALL with t(12;21)(p13.2;q22.1)/ETV6::RUNX1; Classification of B-ALL Provisional entity: B-ALL, ETV6::RUNX1-like; Hematologic neoplasms with germline predisposition associated with a constitutional platelet disorder Myeloid or lymphoid neoplasms with germline ETV6 mutation (PMID: 36422706)	Yes	Yes	Yes	NA	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the ETV6 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
KMT2A	chr11	118,436,456	118,526,832	+	B-lymphoblastic leukaemia/lymphoma with t(v;11q23.3); KMT2A-rearranged, (WHO, PMID: 35732831).	Classification of B-ALL ; B-ALLwith t(v;11q23.3)/KMT2A rearranged. Classification of B-ALL ; Provisional entity: B-ALL, KMT2A rearranged-like (PMID: 36422706)	Yes	No	Yes	NA	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the KMT2A gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
RUNX1	chr21	34,787,801	36,004,667	-	B-lymphoblastic leukaemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1, B-lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion, (WHO, PMID: 35732831).	B-ALL with t(12;21)(p13.2;q22.1)/ETV6::RUNX1 (PMID: 36422706)	Yes	Yes	Yes	NA	Translocation/rearranngement	FUS	ALL	1A for B-ALL, 2 for T-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the RUNX1 gene on chr21 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BCR	chr22	23,179,704	23,318,037	+	Acute myeloid leukaemia with defining genetic abnormalities; acute myeloid leukaemia with BCR::ABL1 fusion. , (WHO, PMID: 35732831). B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion, B-lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1, B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features, B-lymphoblastic leukaemia/lymphoma, BCR-ABL1- like, (WHO, PMID: 35732831).	B-ALL with t(9;22)(q34.1;q11.2)/BCR::ABL1 (PMID: 36422706)	Yes	No	Yes	ABL1	Translocation/rearranngement	FUS	ALL	1A if fused with ABL1, otherwise 3A	Optical Genome Mapping detected a translocation t(9;22)(q34.1;q11.2) with a variant allele frequency (VAF) of [%]. The t(9;22)(q34.1;q11.2) is a recurrent abnormality resulting in a BCR::ABL1 fusion.	In the context of ALL, this variant has unknown prognosis.
ALK	chr2	29,192,774	29,921,611	-	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ALK gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
DNMT3A	chr2	25,232,961	25,252,315	-	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the DNMT3A gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
FBXW7	chr4	152,321,258	152,535,033	-	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FBXW7 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
IKZF1	chr7	50,304,068	50,405,101	+	NA	Acute lymphoblastic leukemia with germline predisposition* ; Acute lymphoblastic leukemia with germline IKZF1 mutation. Classification of B-ALL ; B-ALL with mutated IKZF1 N159Y (PMID: 36422706)	No	Yes	Yes	N.A.	Deletion/CN loss	LOF	ALL	3A or B depending on size	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the IKZF1 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant is associated with a intermediate prognosis (PMID: 36422706).
NOTCH1	chr9	136,494,444	136,545,786	-	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the NOTCH1 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PHF6	chrX	134,373,312	134,428,792	+	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PHF6 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PICALM	chr11	85,957,171	86,069,881	-	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PICALM gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
PTEN	chr10	87,863,438	87,968,775	+	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PTEN gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
STIL	chr1	47,250,138	47,314,147	-	NA	NA	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	2 for T-ALL, 3 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the STIL gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
TAL1	chr1	47,216,290	47,232,225	-	NA	Provinsional entities of T-ALL (PMID: 36422706)	No	Yes	Yes	NA	Deletion/CN loss	LOF	ALL	1A for T-ALL, 2 for B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the TAL1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BCL11B	chr14	99,169,287	99,272,197	-	NA	Early T-cell precursor ALLwith BCL11B rearrangement (PMID: 36422706)	No	Yes	Yes	NA	Translocation/rearranngement	FUS	ALL	1A for T-ALL, 2 for B-ALL	Optical Genome Mapping detected a [Translocation/rearranngement] mutation involving the BCL11B gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ADARB2	chr10	1,177,312	1,737,476	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ADARB2 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ADARB2	chr10	1,265,784	1,265,920	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ADARB2 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ADD3	chr10	110,005,967	110,135,565	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ADD3 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
AFF3	chr2	99,547,254	100,142,575	-	NA	NA	Yes	Yes	No	NA	Deletion/CN loss	LOF	ALL	2 for T/B-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the AFF3 gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ARID5B	chr10	61,901,253	62,096,948	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ARID5B gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ASMTL	chrX	1,403,138	1,453,762	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ASMTL gene on chrX with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ATP10A	chr15	25,678,712	25,863,202	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ATP10A gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
AUTS2	chr7	69,598,919	70,792,899	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the AUTS2 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BCAT1	chr12	24,810,023	24,949,459	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BCAT1 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BCL2L14	chr12	12,071,467	12,099,693	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BCL2L14 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BCL9	chr1	147,541,501	147,626,219	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BCL9 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BIRC3	chr11	102,317,450	102,339,404	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BIRC3 gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BLNK	chr10	96,191,698	96,271,576	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BLNK gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BRD1	chr22	49,773,288	49,824,804	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BRD1 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BTG1	chr12	92,140,278	92,145,897	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BTG1 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
BTLA	chr3	112,463,965	112,499,561	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BTLA gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CD200	chr3	112,333,068	112,362,811	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CD200 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CD79B	chr17	63,928,738	63,932,344	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CD79B gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CDKN2B	chr9	22,002,902	22,009,313	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CDKN2B gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CEBPB	chr20	50,190,582	50,192,690	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CEBPB gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CEBPD	chr8	47,736,913	47,738,164	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CEBPD gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CEBPE	chr14	23,117,305	23,119,611	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CEBPE gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CEBPG	chr19	33,373,668	33,382,686	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CEBPG gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
CHFR	chr12	132,840,351	132,887,618	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CHFR gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
DACH1	chr13	71,437,965	71,867,192	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the DACH1 gene on chr13 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ELN	chr7	74,027,789	74,069,906	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ELN gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
EPS15	chr1	51,354,263	51,519,323	-	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EPS15 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
HIPK1	chr1	113,929,373	113,977,869	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HIPK1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
HIST1H2AD	chr6	26,198,783	26,199,293	NA	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HIST1H2AD gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
HIST1H2BE	chr6	26,183,795	26,184,230	NA	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HIST1H2BE gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
HIST1H2BF	chr6	26,199,558	26,199,988	NA	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HIST1H2BF gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
HIST1H3D	chr6	26,196,783	26,199,293	NA	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HIST1H3D gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
HIST1H4D	chr6	26,188,709	26,189,076	NA	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HIST1H4D gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
ID4	chr6	19,837,386	19,842,200	+	NA	NA	Yes	No	No	NA	Deletion/CN loss	LOF	ALL	2 for B-ALL, 3 for T-ALL	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ID4 gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of ALL, this variant has unknown prognosis.
